Search
for
Sort by
Research 31–60 of 632
- Adverse cutaneous effects of psychotropic medications
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Evaluation of Alopecia
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- Contact Allergic Dermatitis to Quinine in an Anti-hair Loss Lotion
- Drugs that affect autonomic functions or the extrapyramidal system
- Kawasaki disease: an update
- The Contribution of Shaykh Abbas Kuta Karang in Malay Medical: A Study on Al-Rahmah fi Al-Tib wa Al-Hikmah Manuscript
- Gender aspects in skin diseases
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Non-hemorrhage-related adverse effects of rivaroxaban
- Psychoactive drugs and skin
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Fourth Nerve Palsy After Hair Replacement Surgery and Prolonged Vertical Position in a Patient With Mega-Cisterna-Magna: Report of a Case
- Hypersensitivity Diseases
- Index
- Dermatologic therapy: December 1986 to December 1987
- Pharmacology of anabolic steroids
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Hypersensitivity Reactions to Anticoagulant Drugs
- Anticonvulsant-Induced Cutaneous Reactions
- Successful induction of oral tolerance in Netherton syndrome
- Drug eruptions in dermatology
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- Sex hormones and related compounds, including hormonal contraceptives